# Diltiazem Hydrochloride Cream for Anal Fissure

> **NCT01217515** · PHASE3 · COMPLETED · sponsor: **S.L.A. Pharma AG** · enrollment: 465 (actual)

## Conditions studied

- Chronic Anal Fissure

## Interventions

- **DRUG:** Diltiazem hydrochloride 4% cream
- **DRUG:** Diltiazem hydrochloride 2% cream
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01217515
- **Lead sponsor:** S.L.A. Pharma AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2012-03
- **Final completion:** 2012-05
- **Target enrollment:** 465 (ACTUAL)
- **Last updated:** 2014-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01217515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01217515, "Diltiazem Hydrochloride Cream for Anal Fissure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01217515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*